NTA Stakeholders Meeting 2016

Nordic Trial Alliance welcomes you to the meeting “Potential in Nordic Clinical Research Cooperation”.

Time and place


Hotel Bristol, Kristian IVs gate 7, 0164 Oslo Jan 26, 2016 from 10:00 AM to 04:30 PM

Contact person



The meeting takes place at Hotel Bristol in Oslo January 26, 10-16. The theme for the meeting is to report on the outcomes of the Nordic Trial Alliance Project and to discuss ways forward in Nordic clinical research. 

Reserve the date and register here.

Very welcome!

The Nordic Trial Alliance

Please note that the meeting is free of charge but participants pay their own travel costs. Rooms may be reserved at Hotel Bristol for 1345 NOK per room and night, breakfast included (one person). Please use the booking code 250116NORD_002 at the latest 18 January.


Moderator morning session: Kristján Erlendsson, Iceland

10.00 Opening
Bent Høie, Minister of Health and Care Services, Norway

10.15 Nordic Trial Alliance – main achievements

Pierre Lafolie, Project Leader

Reports from NTA implementation projects

10.40 Nordic Research Ethical Procedures
Mika Scheinin, Professor, University of Turku, Finland

11.00 Nordic Monitoring Network
Annette Jørgensen, Head of GCP-unit at Aalborg and Aarhus University Hospitals, Denmark

11.20 Nordic Pediatrics Network
Pirkko Lepola, Executive Secretary FINPEDMED, University of Tampere, Finland

11.40 Nordic clinical research transparency and registration
Christian Gluud, Head of The Copenhagen Trial Unit, Rigshospitalet, Denmark 

12.00-13.00 Lunch

The potential in Nordic medical research?

Moderator afternoon session: Steinar Aamdal, Norway

13.00 Present situation in the Nordic countries

13.30  A CRO perspective on what would attract more Clinical Trials to the Nordic Region
Jan Hellqvist, Regional Managing Director Northern Europe, TFS

14.00 Common Nordic Legal Framework for Future Research?
Marjut Salokannel, Legal Adviser, Finland

14.30 - 14.50  Coffee

Panel Discussion

“The Way Forward in Nordic Clinical Research Cooperation”

Moderator Pierre Lafolie, Nordic Trial Alliance

The ethics committee perspective
Jacob Hølen, Director, The National Committee for Medical and Health Research Ethics (NEM)

The university hospital perspective
Bjørn Eiriksten, CEO, Oslo University Hospital

The industry perspective
Mia Bengtström, Senior Adviser, Pharmaceutical Association, Finland

The research council perspective
Jørgen Frøkiær, Chairman of the Danish Council for Independent Research | Medical Sciences

The patient organisation perspective
Ole Alexander Opdalshei, Norwegian Cancer Society

16.00 Conclusions and way forward

16.30 (at the latest) End of the day


Presentations from the meeting

From the meeting
  • “Collaboration is essential for success”. The fourth annual NTA stakeholders meeting, “Potential in Nordic Clinical Research Cooperation”, was held in Oslo 26 January 2016 and opened by the Norwegian Minister of Health and Care services, Mr Bent Høie. He stated that we have only seen the start of a Nordic collaboration on clinical research and we need to build on the work that has been achieved by Nordic Trial Alliance.
  • Stakeholder Meeting 2016. Presentations from the stakeholder meeting 2016